Weidong Ma

State Key Laboratory Of Druggability Evaluation And Systematic Translational Medicine, Tianjin Key Laboratory Of Digestive Cancer, Key Laboratory Of Cancer Prevention And Therapy
Tianjin, 300060, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Identifying occult high-risk features and stratified management strategies following curative resection for ampullary adenocarcinoma.

Identifying occult high-risk features and stratified management strategies following curative resection for ampullary adenocarcinoma.

Journal: Cancer biology & medicine

Published: October 17, 2025

NALIRIFOX versus gemcitabine plus nab-paclitaxel in Chinese patients with advanced pancreatic adenocarcinoma: a randomized, open-label phase II trial.

NALIRIFOX versus gemcitabine plus nab-paclitaxel in Chinese patients with advanced pancreatic adenocarcinoma: a randomized, open-label phase II trial.

Journal: Nature communications

Published: August 28, 2025

Development and Prospective Validation of a Cell-free DNA-Based Model for the Early Detection of Pancreatic Cancer.

Development and Prospective Validation of a Cell-free DNA-Based Model for the Early Detection of Pancreatic Cancer.

Journal: Cancer discovery

Published: February 26, 2025

Is lung involvement a favorable prognostic factor for pancreatic ductal adenocarcinoma with synchronous liver metastases?-A propensity score analysis.

Is lung involvement a favorable prognostic factor for pancreatic ductal adenocarcinoma with synchronous liver metastases?-A propensity score analysis.

Journal: Expert review of gastroenterology & hepatology

Published: February 21, 2023

Preoperative ultrasound combined with routine blood tests in predicting the malignant risk of pancreatic cystic neoplasms.

Preoperative ultrasound combined with routine blood tests in predicting the malignant risk of pancreatic cystic neoplasms.

Journal: Cancer biology & medicine

Published: November 09, 2022

Construction and application of a prediction model for the delivery outcome of women with scarred uterus based on ultrasonic parameters.

Construction and application of a prediction model for the delivery outcome of women with scarred uterus based on ultrasonic parameters.

Journal: American journal of translational research

Published: October 11, 2022

Systemic Chemotherapy With or Without Hepatic Arterial Infusion Chemotherapy for Liver Metastases From Pancreatic Cancer: A Propensity Score Matching Analysis.

Systemic Chemotherapy With or Without Hepatic Arterial Infusion Chemotherapy for Liver Metastases From Pancreatic Cancer: A Propensity Score Matching Analysis.

Journal: Clinical colorectal cancer

Published: August 22, 2022

MicroRNA-608 promotes apoptosis via BRD4 downregulation in pancreatic ductal adenocarcinoma.

MicroRNA-608 promotes apoptosis via BRD4 downregulation in pancreatic ductal adenocarcinoma.

Journal: Oncology letters

Published: April 14, 2019

LOX and ACSL5 as potential relapse markers for pancreatic cancer patients.

LOX and ACSL5 as potential relapse markers for pancreatic cancer patients.

Journal: Cancer biology & therapy

Published: February 05, 2019

Systemic chemotherapy in combination with liver-directed therapy improves survival in patients with pancreatic adenocarcinoma and synchronous liver metastases.

Systemic chemotherapy in combination with liver-directed therapy improves survival in patients with pancreatic adenocarcinoma and synchronous liver metastases.

Journal: Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]

Published: February 26, 2018

Factors influencing survival of patients with pancreatic adenocarcinoma and synchronous liver metastases receiving palliative care.

Factors influencing survival of patients with pancreatic adenocarcinoma and synchronous liver metastases receiving palliative care.

Journal: Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]

Published: April 23, 2017

Single nucleotide polymorphism in the microRNA-199a binding site of HIF1A gene is associated with pancreatic ductal adenocarcinoma risk and worse clinical outcomes.

Single nucleotide polymorphism in the microRNA-199a binding site of HIF1A gene is associated with pancreatic ductal adenocarcinoma risk and worse clinical outcomes.

Journal: Oncotarget

Published: December 30, 2015

Showing 1-12 of 13

Last Updated: 09/26/2026